title: Miscellaneous treatments, II: niacin and heparin: unapproved uses, dosages, or indications.
authors.affiliation: Dermatology Unit, Kaplan Medical Center, Rechovot, Israel. wolf_r@netvision.net.il
authors.forename: Ronni
authors.initials: R
authors.lastname: Wolf
authors.forename: Edith
authors.initials: E
authors.lastname: Orion
authors.forename: Hagit
authors.initials: H
authors.lastname: Matz
authors.forename: Yalcin
authors.initials: Y
authors.lastname: Tüzün
authors.forename: Binnur
authors.initials: B
authors.lastname: Tüzün
mesh_terms: D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D017277:Drug Approval; D004363:Drug Utilization; D005260:Female; D005500:Follow-Up Studies; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007557:Israel; D008297:Male; D009525:Niacin / Q000008:administration & dosage* / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome; D014421:Turkey
chemical_list: D003879:Dermatologic Agents; D009525:Niacin; D006493:Heparin